The German CPU registry: Comparison of smokers and nonsmokers.

Das Deutsche CPU-Register: Vergleich von Rauchern und Nichtrauchern.

Journal

Herz
ISSN: 1615-6692
Titre abrégé: Herz
Pays: Germany
ID NLM: 7801231

Informations de publication

Date de publication:
May 2020
Historique:
received: 28 02 2018
accepted: 28 06 2018
revised: 22 06 2018
pubmed: 29 7 2018
medline: 1 7 2020
entrez: 29 7 2018
Statut: ppublish

Résumé

Chest pain is a major reason for admission to an internal emergency department, and smoking is a well-known risk factor for coronary artery disease (CAD) and acute coronary syndrome (ACS). The aim of this analysis is to illustrate the differences between smokers and nonsmokers presenting to German chest pain units (CPU) in regard to patient characteristics, CAD manifestation, treatment strategy, and prognosis. From December 2008 to March 2014, 13,902 patients who had a complete 3‑month follow-up were enrolled in the German CPU registry. The analysis comprised 5796 patients with ACS and documented smoking status. Of all the patients in the CPU registry, 35.2% were smokers. Compared with nonsmokers, they were 13.5 years younger (58.2 vs. 71.7 years, p < 0.001), predominantly men (77.1% vs. 65.2%, p < 0.001), and were more frequently diagnosed with single-vessel disease (32.1% vs. 25.2%) as well as ST-elevation myocardial infarction (STEMI; 23.8% vs. 15.5%, p < 0.001). Although the Global Registry of Acute Coronary Events (GRACE) Risk Score for hospital mortality was lower in the group of smokers (106.1 vs. 123.3, p < 0.001), we did not observe any differences in CPU death (0.4% vs. 0.4%, p = 0.69) and CPU major adverse cardiac event (MACE) rates (3.8% vs 2.9%, p = 0.073) between the groups. In the 3‑month follow-up, we documented higher mortality rates in the nonsmoker group (1.9% vs. 2.9%, p = 0.035) in correlation with the GRACE Risk Score (80.3 vs. 105.2, p < 0.001). MACE rates were similar during the follow-up (3.1% vs. 4.1%, p = 0.065). Observations from the German CPU registry demonstrate that smoking is a strong predictor of acute CAD manifestation early in life, especially STEMI. In spite of a lower GRACE Risk Score and fewer comorbidities, smokers had a rate of hospital mortality similar to the older group of nonsmokers.

Sections du résumé

BACKGROUND BACKGROUND
Chest pain is a major reason for admission to an internal emergency department, and smoking is a well-known risk factor for coronary artery disease (CAD) and acute coronary syndrome (ACS). The aim of this analysis is to illustrate the differences between smokers and nonsmokers presenting to German chest pain units (CPU) in regard to patient characteristics, CAD manifestation, treatment strategy, and prognosis.
METHODS METHODS
From December 2008 to March 2014, 13,902 patients who had a complete 3‑month follow-up were enrolled in the German CPU registry. The analysis comprised 5796 patients with ACS and documented smoking status.
RESULTS RESULTS
Of all the patients in the CPU registry, 35.2% were smokers. Compared with nonsmokers, they were 13.5 years younger (58.2 vs. 71.7 years, p < 0.001), predominantly men (77.1% vs. 65.2%, p < 0.001), and were more frequently diagnosed with single-vessel disease (32.1% vs. 25.2%) as well as ST-elevation myocardial infarction (STEMI; 23.8% vs. 15.5%, p < 0.001). Although the Global Registry of Acute Coronary Events (GRACE) Risk Score for hospital mortality was lower in the group of smokers (106.1 vs. 123.3, p < 0.001), we did not observe any differences in CPU death (0.4% vs. 0.4%, p = 0.69) and CPU major adverse cardiac event (MACE) rates (3.8% vs 2.9%, p = 0.073) between the groups. In the 3‑month follow-up, we documented higher mortality rates in the nonsmoker group (1.9% vs. 2.9%, p = 0.035) in correlation with the GRACE Risk Score (80.3 vs. 105.2, p < 0.001). MACE rates were similar during the follow-up (3.1% vs. 4.1%, p = 0.065).
CONCLUSION CONCLUSIONS
Observations from the German CPU registry demonstrate that smoking is a strong predictor of acute CAD manifestation early in life, especially STEMI. In spite of a lower GRACE Risk Score and fewer comorbidities, smokers had a rate of hospital mortality similar to the older group of nonsmokers.

Identifiants

pubmed: 30054712
doi: 10.1007/s00059-018-4733-z
pii: 10.1007/s00059-018-4733-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-298

Auteurs

D Bock (D)

Department of Cardiology, Klinikum Höchst, Gotenstraße 6-8, 65929, Frankfurt am Main, Germany. daniel.bock@klinikumfrankfurt.de.

J Senges (J)

Institut für Herzinfarktforschung, Ludwigshafen, Germany.

C Pohlmann (C)

Department of Cardiology, Klinikum Höchst, Gotenstraße 6-8, 65929, Frankfurt am Main, Germany.

M Hochadel (M)

Institut für Herzinfarktforschung, Ludwigshafen, Germany.

T Münzel (T)

Department of Cardiology, Universitätsklinik Mainz, Mainz, Germany.

E Giannitsis (E)

Department of Cardiology, Universitätsklinik Heidelberg, Heidelberg, Germany.

C Schmitt (C)

Department of Cardiology, Klinikum Karlsruhe, Karlsruhe, Germany.

G Heusch (G)

Institute for Pathophysiology, Universitätsklinik Essen, Essen, Germany.

T Voigtländer (T)

Cardiovascular Center Bethanien, Frankfurt/Main, Germany.

H Mudra (H)

Department of Cardiology, Städtisches Klinikum München, Munich, Germany.

B Schumacher (B)

2nd Department of Medicine, Westpfalzklinikum Kaiserslautern, Kaiserslautern, Germany.

H Darius (H)

Department of Cardiology, Vivantes Hospital Neukölln, Berlin, Germany.

L S Maier (LS)

Department of Cardiology, University of Regensburg, Regensburg, Germany.

B Hailer (B)

Department of Cardiology, Katholisches Klinikum Essen, Essen, Germany.

M Haude (M)

Lukaskrankenhaus, Städtische Kliniken Neuss, Neuss, Germany.

H Gohlke (H)

Universitäts-Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany.

U Hink (U)

Department of Cardiology, Klinikum Höchst, Gotenstraße 6-8, 65929, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH